Embecta (EMBC) Depreciation & Amortization (CF) (2020 - 2026)
Embecta (EMBC) posted Depreciation & Amortization (CF) of $10.2 million for Q1 2026, down 0.97% sequentially from $10.3 million in Q4 2025, and up 13.33% YoY from $9.0 million in Q1 2025.
Embecta (EMBC) Depreciation & Amortization (CF) (2020 - 2026) Analysis & Trends
Embecta has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $10.2 million in Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 13.33% year-over-year to $10.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $42.8 million (up 16.3% YoY) and the FY2025 annual result came in at $40.7 million, up 12.43% from the prior year.
- Depreciation & Amortization (CF) fell to $10.2 million in Q1 2026 per EMBC's latest filing, from $10.3 million in the prior quarter.
- Over five years, Depreciation & Amortization (CF) peaked at $13.1 million in Q3 2025 and troughed at $6.7 million in Q1 2022.
- A 5-year average of $9.0 million and a median of $9.0 million in 2024 frame the typical range for Depreciation & Amortization (CF).
- The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) tumbled 34.31% in 2022, then jumped 37.89% in 2025.
- Over 5 years, Depreciation & Amortization (CF) stood at $7.2 million in 2022, then climbed by 22.22% to $8.8 million in 2023, then grew by 6.82% to $9.4 million in 2024, then increased by 9.57% to $10.3 million in 2025, then dropped by 0.97% to $10.2 million in 2026.
- According to Business Quant data, Depreciation & Amortization (CF) over the past three periods registered $10.2 million, $10.3 million, and $13.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 134.13 Bn | 128.91 Bn | 1.96 Bn | 192.30 Mn |
| 2 | Becton Dickinson | 52.76 Bn | 51.90 Bn | 2.32 Bn | 564.00 Mn |
| 3 | Alcon | 35.81 Bn | 34.46 Bn | 1.68 Bn | - |
| 4 | Resmed | 33.72 Bn | 32.25 Bn | 861.22 Mn | 44.78 Mn |
| 5 | Medline | 29.38 Bn | 26.70 Bn | 2.22 Bn | 256.00 Mn |
| 6 | West Pharmaceutical Services | 25.00 Bn | 24.57 Bn | 329.20 Mn | - |
| 7 | Solventum | 15.46 Bn | 15.06 Bn | 1.29 Bn | 133.00 Mn |
| 8 | Cooper Companies | 14.88 Bn | 14.74 Bn | 735.40 Mn | 95.40 Mn |
| 9 | Baxter International | 13.58 Bn | 11.43 Bn | 1.03 Bn | 239.00 Mn |
| 10 | Embecta | 305.26 Mn | 87.06 Mn | 153.30 Mn | 10.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.60 Mn |
| Jun 30, 2026 | 10.60 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Mar 31, 2026 | 10.20 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Dec 31, 2025 | 10.30 Mn |
| Sep 30, 2025 | 13.10 Mn |
| Sep 30, 2025 | 13.10 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Jun 30, 2025 | 9.20 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Mar 31, 2025 | 9.00 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Dec 31, 2024 | 9.40 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Jun 30, 2024 | 8.90 Mn |
| Mar 31, 2024 | 9.00 Mn |
| Mar 31, 2024 | 9.00 Mn |